| CXSL2400311 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.3) | New Drug Application | 2024-05-14 | | | | | view |
| JYSB2000548 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-11-11 | view |
| CXSL2400588 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.3) | New Drug Application | 2024-09-04 | | | | | view |
| JYSB2100029 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-01-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-07-13 | view |
| CXSL2300902 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.3) | New Drug Application | 2023-12-28 | | Anhui Zhifei Longcom Biopharmaceutical Co Ltd | | | view |
| JYSB1900251 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2019-09-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-09-30 | view |
| JYSB2400143 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2024-07-04 | | GlaxoSmithKline Biologicals SA | | | view |
| JYSB2000614 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |
| CXSL2300518 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(3.3) | New Drug Application | 2023-07-27 | | | | | view |
| JYSB2000172 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-05-16 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-07-16 | view |
| JYSB2400172 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2024-08-09 | | GlaxoSmithKline Biologicals SA | | | view |
| JYSB2100028 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-01-19 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-07-13 | view |
| CXSL2300817 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.3) | New Drug Application | 2023-11-28 | | Shanghai Institute of Biological Products Co Ltd | | | view |
| JYSB2400136 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2024-06-27 | | GlaxoSmithKline Biologicals SA | | | view |
| JYSB2000612 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-14 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |
| CXSL2300431 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.2) | New Drug Application | 2023-06-27 | | | | | view |
| CXSL2400153 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.2) | New Drug Application | 2024-02-23 | | | | | view |
| JYSB2000680 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products | Supplementary Application | 2020-12-29 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-08-05 | view |
| CXSL2300818 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.3) | New Drug Application | 2023-11-28 | | Shanghai Institute of Biological Products Co Ltd | | | view |
| CXSL2400350 | 重组带状疱疹疫苗（CHO细胞） | Recombinant Zoster Vaccine(CHO Cell) | Injection | Biological Products(1.2) | New Drug Application | 2024-05-28 | | | | | view |
